GlassScriptPhysician profile
Parthiv S Mehta
NPI 1962539759
$148,877.57
in general payments reported to CMS, 2019-2025
31 companies · $35K in 2025
The $35K reported for 2025 was more than what 99% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,079 · 2020: $1,614 · 2021: $13K · 2022: $28K · 2023: $29K · 2024: $34K · 2025: $35K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $55K · Consulting Fee: $31K · Food and Beverage: $6,811 · Travel and Lodging: $5,621.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $55,305.90 |
| Consulting Fee | $30,558.00 |
| Food and Beverage | $6,810.55 |
| Travel and Lodging | $5,621.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $85,256.87 | 2019-2025 | Spaceoar Vue System - 10ml, Spaceoar System, Rezum Generator |
| Bioprotect Medical, INC. | $13,119.88 | 2024-2025 | Bioprotect Balloon Implant System |
| Teleflex LLC | $12,777.67 | 2024-2025 | Urolift, Barrigel |
| Palette Life Sciences, INC. | $11,981.10 | 2022-2023 | |
| Augmenix, INC. | $6,250.00 | 2019 | |
| Novartis Pharmaceuticals Corporation | $3,559.28 | 2023-2025 | |
| Angiodynamics, INC. | $3,397.49 | 2023-2025 | Nanoknife, Angiovac |
| Bayer Healthcare Pharmaceuticals INC. | $3,241.58 | 2019-2025 | |
| Photocure INC | $2,924.24 | 2022 | |
| Isoray, INC | $1,448.65 | 2019-2023 | Brachytherapy Source |
| Janssen Biotech, INC. | $804.52 | 2019-2025 | Erleada |
| Dendreon Pharmaceuticals LLC | $728.34 | 2019-2025 | Provenge |
| Astellas Pharma US INC | $567.50 | 2019-2025 | Xtandi |
| Blue Earth Diagnostics | $534.49 | 2019-2025 | Posluma |
| Pfizer INC. | $504.18 | 2019-2025 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $497.58 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $226.68 | 2023-2024 | Orgovyx |
| Merck Sharp & Dohme LLC | $138.32 | 2021-2024 | Keytruda, Lynparza |
| Tolmar Pharmaceuticals, INC. | $136.47 | 2021-2022 | |
| Bard Peripheral Vascular, INC. | $121.78 | 2022 | |
| Accord Healthcare, INC. | $109.02 | 2022-2024 | |
| Amgen INC. | $98.84 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $90.36 | 2020-2025 | |
| Progenics Pharmaceuticals, INC. | $86.70 | 2021-2025 | Pylarify |
| Myriad Genetic Laboratories, INC. | $84.14 | 2020-2024 | Prolaris, Myrisk |
| Astrazeneca Pharmaceuticals LP | $46.20 | 2022 | |
| Telix Pharmaceuticals | $43.95 | 2023 | Illuccix |
| Abbvie INC. | $36.44 | 2021-2025 | |
| Janssen Scientific Affairs, LLC | $23.27 | 2024 | Erleada |
| Clarus Therapeutics INC. | $23.16 | 2021 | |
| Cardinal Health 414 LLC | $18.87 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Parthiv Mehta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.